HCA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs

$410.50

Marktkapitalisierung

$104.86B

P/E (TTM)

16.5

EPS (TTM)

$28.33

Umsatz (TTM)

$75.60B

Dividendenrendite

0.65%

ROE

-159.1%

Verschuldungsgrad

-6.9

52W-Spanne

$330 – $557

HCA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $75.60B

2016-12-31 → 2025-12-31

EPS $28.33

2016-12-31 → 2025-12-31

Freier Cashflow $7.69B

2016-12-31 → 2025-12-31

Margen 9.0%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl

5-Jahres-Trend

HCA

Peer-Median

P/E (TTM)

16.5

13.9

P/S (TTM) (K/V (TTM))

1.4

0.9

P/B (K/B)

-17.4

1.2

EV / EBITDA

41.3

—

Price / FCF (Kurs / FCF)

13.6

—

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl

5-Jahres-Trend

HCA

Peer-Median

Net Profit Margin (Nettogewinnmarge)

9.0%

3.0%

ROA

11.3%

2.6%

ROE

-159.1%

5.8%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl

5-Jahres-Trend

HCA

Peer-Median

Debt / Equity (Fremdkapital / Eigenkapital)

-6.9

74.0

Current Ratio (Liquiditätsgrad)

1.0

1.2

Quick Ratio

0.7

—

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl

5-Jahres-Trend

HCA

Peer-Median

Revenue YoY (Umsatz YoY)

7.1%

—

Revenue CAGR 3Y (Umsatz CAGR 3J)

7.9%

—

Revenue CAGR 5Y (Umsatz CAGR 5J)

8.0%

—

EPS YoY (EPS VjV)

28.8%

—

Net Income YoY (Nettogewinn YoY)

17.8%

—

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl

5-Jahres-Trend

HCA

Peer-Median

EPS (Diluted) (EPS (Verwässert))

$28.33

—

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl

5-Jahres-Trend

HCA

Peer-Median

Payout Ratio (Ausschüttungsquote)

10.0%

—

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite

0.65%

Ausschüttungsquote

10.0%

5J Div CAGR

—

Ex-Datum	Betrag
16. Juni 2026	$0,7800
17. März 2026	$0,7800
15. Dezember 2025	$0,7200
16. September 2025	$0,7200
16. Juni 2025	$0,7200
17. März 2025	$0,7200
13. Dezember 2024	$0,6600
16. September 2024	$0,6600
14. Juni 2024	$0,6600
14. März 2024	$0,6600
13. Dezember 2023	$0,6000
14. September 2023	$0,6000
15. Juni 2023	$0,6000
16. März 2023	$0,6000
13. Dezember 2022	$0,5600
15. September 2022	$0,5600
15. Juni 2022	$0,5600
16. März 2022	$0,5600
13. Dezember 2021	$0,4800
15. September 2021	$0,4800

HCA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 30 Analysten

Starker Kauf 6 20,0%
Kauf 13 43,3%
Halten 10 33,3%
Verkauf 1 3,3%
Starker Verkauf 0 0,0%

12-Monats-Kursziel

21 Analysten · 2026-06-29

Median $510.00

Jetzt $410.50

Tief $396.00

Hoch $635.00

Median-Ziel $510.00 +24,2%

Mittelwert-Ziel $500.29 +21,9%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung

0.57%

Nächster Bericht

Jul 23, 2026

Zeitraum	EPS Actual	EPS est.	Überraschung
31. März 2026	$7.15	$7.21	-0.06%
31. Dezember 2025	$8.14	$7.53	0.61%
30. September 2025	$6.96	$5.77	1.2%
30. Juni 2025	$6.83	$6.31	0.52%
31. März 2025	$6.45	$5.84	0.61%

Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker	Marktkapitalisierung	P/E	Umsatz Vj.	Nettomarge	ROE	Bruttogewinnmarge
HCA	$104.86B	16.5	7.1%	9.0%	-159.1%	—
THC	$17.28B	12.8	3.1%	11.1%	56.4%	—
EHC	$10.61B	19.2	10.5%	9.5%	25.1%	—
ENSG	$10.12B	29.8	18.7%	6.8%	16.9%	—
UHS	—	9.4	9.7%	8.6%	21.4%	—
PACS	$6.01B	31.5	29.3%	3.6%	23.1%	—
CON	$2.53B	15.1	13.9%	7.7%	49.8%	—
BKD	$2.57B	-9.6	2.2%	-8.2%	-313.2%	26.2%
ACHC	$1.28B	-1.2	5.0%	-33.3%	-43.9%	—
SGRY	$2.00B	-25.3	6.2%	-2.4%	-4.5%	—

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 12

Jährliche Gewinn- und Verlustrechnung-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	$75.60B	$70.60B	$64.97B	$60.23B	$58.75B	$51.53B	$51.34B	$46.68B	$43.61B	$41.49B
SG&A Expense	$548M	$421M	$353M	$307M	$337M	$416M	$370M	$344M	$340M	$343M
Operating Expenses	$65.77B	$62.08B	$57.26B	$51.65B	$48.92B	$46.10B	$46.09B	$41.34B	$39.23B	$36.68B
Interest Expense	$2.25B	$2.06B	$1.94B	$1.74B	$1.57B	$1.58B	$1.82B	$1.75B	$1.69B	$1.71B
Pretax Income	$9.83B	$8.52B	$7.71B	$8.58B	$9.83B	$5.43B	$5.24B	$5.33B	$4.38B	$4.81B
Income Tax	$2.05B	$1.87B	$1.61B	$1.75B	$2.11B	$1.04B	$1.10B	$946M	$1.64B	$1.38B
Net Income	$6.78B	$5.76B	$5.24B	$5.64B	$6.96B	$3.75B	$3.50B	$3.79B	$2.22B	$2.89B
EPS (Basic)	$28.70	$22.27	$19.25	$19.43	$21.52	$11.10	$10.27	$10.90	$6.12	$7.53
EPS (Diluted)	$28.33	$22.00	$18.97	$19.15	$21.16	$10.93	$10.07	$10.66	$5.95	$7.30
Shares (Basic)	236,413,000	258,603,000	272,404,000	290,348,000	323,315,000	338,274,000	341,210,000	347,297,000	362,305,000	383,591,000
Shares (Diluted)	239,495,000	261,806,000	276,412,000	294,666,000	328,752,000	343,605,000	348,226,000	355,303,000	372,221,000	395,851,000
EBITDA	$3.52B	$3.31B	$3.08B	$2.97B	$2.85B	$2.72B	$2.60B	$2.28B	$2.13B	$1.97B

Bilanz 22

Jährliche Bilanz-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	$1.04B	$1.93B	$935M	$908M	$1.45B	$1.79B	$621M	$502M	$732M	$646M
Short-term Investments	·	·	·	·	·	$116M	$147M	$47M	$54M	$49M
Receivables	$10.87B	$10.75B	$9.96B	$8.89B	$8.10B	$7.05B	$7.38B	$6.79B	$6.50B	$5.83B
Inventory	$1.65B	$1.74B	$2.02B	$2.07B	$1.99B	$2.02B	$1.85B	$1.73B	$1.57B	$1.50B
Other Current Assets	$2.22B	$1.99B	$2.01B	$1.78B	$2.01B	$1.46B	$1.35B	$1.19B	$1.17B	$1.11B
Current Assets	$15.78B	$16.41B	$14.93B	$13.64B	$13.54B	$12.33B	$11.20B	$10.21B	$9.98B	$9.09B
PP&E (Net)	$31.14B	$29.41B	$27.71B	$25.57B	$24.06B	$23.20B	$22.71B	$19.76B	$17.89B	$16.35B
PP&E (Gross)	$66.28B	$62.51B	$58.55B	$54.76B	$51.35B	$49.32B	$47.23B	$42.97B	$40.08B	$37.05B
Accum. Depreciation	$35.13B	$33.10B	$30.83B	$29.18B	$27.29B	$26.12B	$24.52B	$23.21B	$22.19B	$20.70B
Other Non-current Assets	$255M	$230M	$184M	$298M	$598M	$546M	$480M	$690M	$710M	$1.07B
Total Assets	$60.72B	$59.51B	$56.21B	$52.44B	$50.74B	$47.49B	$45.06B	$39.21B	$36.59B	$33.76B
Accounts Payable	$4.66B	$4.28B	$4.23B	$4.24B	$4.11B	$3.54B	$2.90B	$2.58B	$2.61B	$2.32B
Current Liabilities	$16.35B	$15.18B	$12.65B	$9.90B	$9.58B	$8.70B	$7.76B	$7.57B	$6.16B	$5.83B
Capital Leases	$1.85B	$1.86B	$1.90B	$1.75B	$1.75B	$1.67B	$1.50B	·	·	·
Total Liabilities	·	·	·	·	·	·	$45.62B	$42.12B	$41.59B	$39.39B
Long-term Debt	$44.28B	$43.03B	$39.59B	$38.08B	$34.58B	$31.00B	$33.72B	$32.82B	$33.06B	$31.38B
Total Debt	$41.60B	$43.03B	$39.59B	$38.08B	$34.58B	$31.00B	$33.72B	$32.82B	$33.06B	$31.38B
Retained Earnings	$-5.72B	$-2.12B	$-1.35B	$-2.28B	$-532M	$777M	$-2.35B	$-4.57B	$-6.53B	$-6.97B
AOCI	$-305M	$-387M	$-425M	$-490M	$-404M	$-502M	$-460M	$-381M	$-278M	$-338M
Stockholders' Equity	$-6.03B	$-2.50B	$-1.77B	$-2.77B	$-933M	$572M	$-2.81B	$-4.95B	$-6.81B	$-7.30B
Liabilities + Equity	$60.72B	$59.51B	$56.21B	$52.44B	$50.74B	$47.49B	$45.06B	$39.21B	$36.59B	$33.76B
Shares Outstanding	224,605,100	249,981,400	265,537,300	277,378,300	305,476,800	339,425,600	338,445,600	342,895,200	350,091,600	370,535,900

Cashflow 17

Jährliche Cashflow-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
D&A	$3.52B	$3.31B	$3.08B	$2.97B	$2.85B	$2.72B	$2.60B	$2.28B	$2.13B	$1.97B
Stock-based Comp	$401M	$360M	$262M	$341M	$440M	$362M	$347M	$268M	$270M	$251M
Amort. of Intangibles	$12M	$16M	$20M	$44M	$25M	$26M	·	·	·	·
Other Non-cash	$1.93B	$1.08B	$850M	$-431M	$-1.29B	$2.40B	$1.07B	$461M	$-3.53B	$-2.67B
Operating Cash Flow	$12.64B	$10.51B	$9.43B	$8.52B	$8.96B	$9.23B	$7.60B	$6.76B	$5.43B	$5.65B
CapEx	$4.94B	$4.88B	$4.74B	$4.39B	$3.58B	$2.83B	$4.16B	$3.57B	$3.02B	$2.76B
Investing Cash Flow	$-4.99B	$-4.93B	$-5.32B	$-3.39B	$-2.64B	$-3.39B	$-5.72B	$-3.90B	$-4.28B	$-3.24B
Debt Issued	$8.47B	$7.50B	$3.22B	$6.00B	$4.34B	$2.70B	$6.45B	$2.00B	$1.50B	$5.40B
Net Debt Issued	$1.08B	$5.08B	$2.31B	$3.17B	$475M	$-737M	$1.13B	$296M	$749M	$925M
Stock Repurchased	$10.07B	$6.04B	$3.81B	$7.00B	$8.21B	$441M	$1.03B	$1.53B	$2.05B	$2.75B
Net Stock Activity	$-10.07B	$-6.04B	$-3.81B	$-7.00B	$-8.21B	$-441M	$-1.03B	$-1.53B	$-2.05B	$-2.75B
Dividends Paid	$679M	$690M	$661M	$653M	$624M	$153M	$550M	$487M	$0	·
Financing Cash Flow	$-8.55B	$-4.58B	$-4.09B	$-5.66B	$-6.66B	$-4.68B	$-1.77B	$-3.08B	$-1.06B	$-2.51B
Net Change in Cash	$-893M	$998M	$27M	$-543M	$-342M	$1.17B	$119M	$-230M	$86M	$-95M
Taxes Paid	$1.74B	$1.84B	$1.39B	$1.18B	$2.18B	$1.00B	$849M	$872M	$1.21B	$1.25B
Free Cash Flow	$7.69B	$5.64B	$4.69B	$4.13B	$5.38B	$6.40B	$3.44B	$3.19B	$2.41B	$2.89B
Levered FCF	$5.91B	$4.03B	$3.16B	$2.74B	$4.15B	$5.12B	$2.00B	$1.74B	$1.35B	$1.68B

Rentabilität 5

Jährliche Rentabilität-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Margin	9.0%	8.2%	8.1%	9.4%	11.8%	7.3%	6.8%	8.1%	·	·
Pretax Margin	13.0%	12.1%	11.9%	14.2%	16.7%	10.5%	10.2%	11.4%	·	·
EBITDA Margin	4.7%	4.7%	4.7%	4.9%	4.9%	5.3%	5.1%	4.9%	·	·
ROA	11.3%	10.0%	9.7%	10.9%	14.2%	8.1%	8.3%	10.0%	6.3%	8.7%
ROE	-159.1%	-269.6%	-230.9%	-305.0%	-3853.7%	-335.8%	-90.4%	-64.4%	-31.4%	-38.8%

Liquidität & Solvenz 4

Jährliche Liquidität & Solvenz-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Current Ratio	1.0	1.1	1.2	1.4	1.4	1.4	1.4	1.3	1.6	1.6
Quick Ratio	0.7	0.8	0.9	1.0	1.0	1.0	1.1	1.0	1.2	1.1
Debt / Equity	-6.9	-17.2	-22.3	-13.8	-37.1	54.2	-12.0	-6.6	-4.9	-4.3
LT Debt / Equity	-6.9	-15.3	-21.0	-13.6	-36.8	53.8	-12.0	-6.5	-4.8	-4.3

Effizienz 2

Jährliche Effizienz-Daten für HCA
Kennzahl	Trend	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Asset Turnover		1.3	1.2	1.2	1.2	1.2	1.1	1.2	1.2	·	·
Receivables Turnover		7.0	6.8	6.9	7.1	7.8	7.1	7.2	7.0	·	·

Pro Aktie 6

Jährliche Pro Aktie-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Book Value / Share	$-26.83	$-10.00	$-6.68	$-9.98	$-3.05	$1.69	$-8.30	$-14.44	$-19.44	$-19.71
Revenue / Share	$315.66	$269.68	$235.04	$204.41	$178.71	$149.98	$147.42	$131.37	·	·
Cash Flow / Share	$52.76	$40.16	$34.12	$28.92	$27.25	$26.87	$21.83	$19.03	$14.58	$14.28
Cash / Share	$4.63	$7.73	$3.52	$3.27	$4.75	$5.28	$1.83	$1.46	$2.09	$1.74
Dividend / Share	$3	$3	$2	$2	$2	$0	$2	$1	·	·
EPS (TTM)	$28.33	$22.00	$18.97	$19.15	$21.16	$10.93	$10.07	$10.66	$5.95	$7.30

Wachstumsraten 10

Jährliche Wachstumsraten-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue YoY	7.1%	8.7%	7.9%	2.5%	14.0%	·	·	·	·	·
Revenue CAGR 3Y	7.9%	6.3%	8.0%	·	·	·	·	·	·	·
Revenue CAGR 5Y	8.0%	·	·	·	·	·	·	·	·	·
EPS YoY	28.8%	16.0%	-0.94%	-9.5%	93.6%	·	·	·	·	·
EPS CAGR 3Y	13.9%	1.3%	20.2%	·	·	·	·	·	·	·
EPS CAGR 5Y	21.0%	·	·	·	·	·	·	·	·	·
Net Income YoY	17.8%	9.9%	-7.1%	-18.9%	85.3%	·	·	·	·	·
Net Income CAGR 3Y	6.3%	-6.1%	11.8%	·	·	·	·	·	·	·
Net Income CAGR 5Y	12.6%	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	34.7%	·	·	·	·	·	·	·	·	·

Bewertung (TTM) 17

Jährliche Bewertung (TTM)-Daten für HCA
Kennzahl	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue TTM	$75.60B	$70.60B	$64.97B	$60.23B	$58.75B	$51.53B	$51.34B	$46.68B	$43.61B	$41.49B
Net Income TTM	$6.78B	$5.76B	$5.24B	$5.64B	$6.96B	$3.75B	$3.50B	$3.79B	$2.22B	$2.89B
Market Cap	$104.86B	$75.03B	$71.88B	$66.56B	$78.48B	$55.82B	$50.03B	$42.67B	$30.75B	$27.43B
Enterprise Value	$145.42B	$116.13B	$110.53B	$103.74B	$111.61B	$84.92B	$82.98B	$74.95B	$63.02B	$58.11B
P/E	16.5	13.6	14.3	12.5	12.1	15.0	14.7	11.7	14.8	10.1
P/S	1.4	1.1	1.1	1.1	1.3	1.1	1.0	0.9	0.7	0.7
P/B	-17.4	-30.0	-40.5	-24.1	-84.1	97.6	-17.8	-8.6	-4.5	-3.8
P / Tangible Book	·	·	·	·	·	97.6	·	·	·	·
P / Cash Flow	8.3	7.1	7.6	7.8	8.8	6.0	6.6	6.3	5.7	4.9
P / FCF	13.6	13.3	15.3	16.1	14.6	8.7	14.5	13.4	12.8	9.5
EV / EBITDA	41.3	35.1	35.9	34.9	39.1	31.2	32.0	32.9	29.6	29.6
EV / FCF	18.9	20.6	23.6	25.1	20.7	13.3	24.1	23.5	26.1	20.1
EV / Revenue	1.9	1.6	1.7	1.7	1.9	1.6	1.6	1.6	1.4	1.4
Dividend Yield	0.65%	0.92%	0.92%	0.98%	0.80%	0.27%	1.1%	1.1%	0.00%	·
Earnings Yield	6.1%	7.3%	7.0%	8.0%	8.2%	6.7%	6.8%	8.6%	6.8%	9.9%
Payout Ratio	10.0%	12.0%	12.6%	11.6%	9.0%	4.1%	15.7%	12.9%	·	·
Annual Payout	$679M	$690M	$661M	$653M	$624M	$153M	$550M	$487M	$0	·

Gewinn- und Verlustrechnung 12

Vierteljährliche Gewinn- und Verlustrechnung-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$19.11B	$19.51B	$19.16B	$18.61B	$18.32B	$18.29B	$17.49B	$17.49B	$17.34B	$17.30B	$16.21B	$15.86B	$15.59B	$15.50B	$14.97B	$14.82B
SG&A Expense	$133M	$153M	$139M	$130M	$126M	$120M	$111M	$100M	$90M	$108M	$89M	$82M	$74M	$79M	$74M	$77M
Operating Expenses	$16.82B	$16.84B	$16.74B	$16.19B	$15.99B	$16.15B	$15.58B	$15.26B	$15.09B	$14.96B	$14.58B	$14.05B	$13.67B	$12.20B	$13.27B	$13.06B
Interest Expense	$584M	$572M	$561M	$568M	$547M	$528M	$515M	$506M	$512M	$491M	$483M	$485M	$479M	$453M	$446M	$434M
Pretax Income	$2.29B	$2.67B	$2.42B	$2.42B	$2.33B	$2.13B	$1.91B	$2.24B	$2.25B	$2.35B	$1.63B	$1.81B	$1.92B	$3.30B	$1.70B	$1.76B
Income Tax	$430M	$509M	$515M	$524M	$502M	$447M	$424M	$550M	$445M	$484M	$355M	$397M	$379M	$656M	$360M	$381M
Net Income	$1.62B	$1.88B	$1.64B	$1.65B	$1.61B	$1.44B	$1.27B	$1.46B	$1.59B	$1.61B	$1.08B	$1.19B	$1.36B	$2.08B	$1.13B	$1.16B
EPS (Basic)	$7.25	$8.22	$7.05	$6.91	$6.52	$5.72	$4.94	$5.60	$6.01	$6.00	$3.98	$4.35	$4.92	$7.30	$3.97	$3.95
EPS (Diluted)	$7.15	$8.09	$6.96	$6.83	$6.45	$5.66	$4.88	$5.53	$5.93	$5.92	$3.91	$4.29	$4.85	$7.20	$3.91	$3.90
Shares (Basic)	223,588,000	-482,587,000	232,891,000	239,173,000	246,936,000	-523,751,000	256,763,000	261,156,000	264,435,000	-550,173,000	271,173,000	274,494,000	276,910,000	-590,583,000	285,958,000	292,527,000
Shares (Diluted)	226,652,000	-488,037,000	236,181,000	241,911,000	249,440,000	-530,198,000	259,917,000	264,071,000	268,016,000	-558,171,000	275,424,000	278,198,000	280,961,000	-598,621,000	289,852,000	296,061,000
EBITDA	$930M	·	$889M	$863M	$860M	·	$842M	$819M	$795M	·	$769M	$763M	$756M	·	$749M	$738M

Bilanz 20

Vierteljährliche Bilanz-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$940M	$1.04B	$997M	$939M	$1.06B	$1.93B	$2.89B	$831M	$1.28B	·	$891M	$862M	$842M	·	$999M	$858M
Receivables	$11.32B	$10.87B	$10.43B	$10.46B	$11.09B	$10.75B	$9.91B	$10.24B	$10.04B	·	$9.18B	$8.71B	$8.66B	·	$8.55B	$8.63B
Inventory	$1.68B	$1.65B	$1.73B	$1.79B	$1.79B	$1.74B	$1.78B	$1.80B	$1.90B	·	$2.03B	$2.05B	$2.08B	·	$2.01B	$2.04B
Other Current Assets	$2.11B	$2.22B	$2.13B	$2.37B	$2.32B	$1.99B	$2.08B	$2.30B	$2.05B	·	$2.19B	$2.26B	$1.96B	·	$1.92B	$2.41B
Current Assets	$16.05B	$15.78B	$15.29B	$15.56B	$16.26B	$16.41B	$16.66B	$15.17B	$15.28B	·	$14.29B	$13.89B	$13.54B	·	$13.48B	$13.94B
PP&E (Net)	$31.47B	$31.14B	$30.57B	$30.12B	$29.74B	$29.41B	$29.05B	$28.64B	$28.10B	·	$27.12B	$26.64B	$26.05B	·	$24.98B	$24.59B
PP&E (Gross)	$67.36B	$66.28B	$65.49B	$64.39B	$63.68B	$62.51B	$61.75B	$60.62B	$59.44B	·	$57.77B	$56.67B	$55.46B	·	$53.73B	$52.82B
Accum. Depreciation	$35.89B	$35.13B	$34.92B	$34.27B	$33.94B	$33.10B	$32.70B	$31.99B	$31.34B	·	$30.66B	$30.02B	$29.41B	·	$28.75B	$28.23B
Other Non-current Assets	$326M	$255M	$277M	$236M	$226M	$230M	$309M	$240M	$199M	·	$200M	$196M	$319M	·	$461M	$514M
Total Assets	$61.45B	$60.72B	$59.75B	$59.54B	$59.80B	$59.51B	$59.46B	$57.38B	$56.96B	$56.21B	$54.59B	$53.59B	$52.71B	$52.44B	$51.48B	$51.58B
Accounts Payable	$4.81B	$4.66B	$4.55B	$4.25B	$4.49B	$4.28B	$4.24B	$4.03B	$4.74B	·	$4.14B	$3.82B	$3.77B	·	$4.16B	$3.74B
Current Liabilities	$19.26B	$16.35B	$17.90B	$15.94B	$13.63B	$15.18B	$14.90B	$14.30B	$13.14B	·	$12.41B	$11.54B	$11.03B	·	$9.78B	$9.00B
Capital Leases	$1.82B	$1.85B	$1.84B	$1.88B	$1.86B	$1.86B	$1.92B	$1.89B	$1.91B	·	$1.78B	$1.81B	$1.72B	·	$1.76B	$1.80B
Long-term Debt	$44.37B	$44.28B	$42.60B	$42.70B	$44.58B	$43.03B	$42.97B	$40.88B	$40.19B	·	$39.35B	$38.93B	$38.86B	·	$37.71B	$38.90B
Total Debt	$39.49B	·	$38.40B	$39.38B	$44.58B	·	$42.97B	$40.88B	$40.19B	·	$39.35B	$38.93B	$38.86B	·	$37.71B	$38.90B
Retained Earnings	$-5.98B	$-5.72B	$-5.02B	$-4.09B	$-3.16B	$-2.12B	$-1.81B	$-1.17B	$-1.19B	·	$-1.99B	$-1.85B	$-2.03B	·	$-2.78B	$-3.17B
AOCI	$-327M	$-305M	$-317M	$-309M	$-357M	$-387M	$-378M	$-433M	$-433M	$-425M	$-491M	$-456M	$-470M	$-490M	$-592M	$-515M
Stockholders' Equity	$-6.30B	$-6.03B	$-5.33B	$-4.39B	$-3.52B	$-2.50B	$-2.18B	$-1.60B	$-1.61B	·	$-2.48B	$-2.30B	$-2.50B	·	$-3.37B	$-3.68B
Liabilities + Equity	$61.45B	$60.72B	$59.75B	$59.54B	$59.80B	$59.51B	$59.46B	$57.38B	$56.96B	·	$54.59B	$53.59B	$52.71B	·	$51.48B	$51.58B
Shares Outstanding	222,530,900	224,605,100	229,845,100	236,143,900	242,955,400	249,981,400	254,517,700	259,237,600	263,215,800	·	268,967,300	272,931,700	275,939,900	·	283,903,500	287,004,400

Cashflow 16

Vierteljährliche Cashflow-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$930M	$911M	$889M	$863M	$860M	$856M	$842M	$819M	$795M	$789M	$769M	$763M	$756M	$750M	$749M	$738M
Stock-based Comp	$86M	$100M	$104M	$99M	$98M	$85M	$76M	$112M	$87M	$57M	$72M	$56M	$77M	$83M	$87M	$85M
Other Non-cash	$-622M	·	·	·	$-917M	·	·	·	$-4M	·	·	·	$-393M	·	·	·
Operating Cash Flow	$2.01B	$2.36B	$4.42B	$4.21B	$1.65B	$2.56B	$3.52B	$1.97B	$2.47B	$2.67B	$2.48B	$2.48B	$1.80B	$2.53B	$3.02B	$1.63B
CapEx	$1.12B	$1.49B	$1.29B	$1.18B	$991M	$1.28B	$1.19B	$1.28B	$1.12B	$1.16B	$1.15B	$1.24B	$1.20B	$1.32B	$1.13B	$1.08B
Investing Cash Flow	$-1.28B	$-1.32B	$-1.39B	$-1.25B	$-1.03B	$-1.35B	$-1.35B	$-1.33B	$-903M	$-1.60B	$-1.31B	$-1.26B	$-1.15B	$-793M	$-546M	$-1.21B
Debt Issued	$0	$3.24B	$0	$0	$5.23B	$0	$3.01B	$0	$4.48B	$4M	$2M	$3.22B	$0	$21M	$10M	$0
Net Debt Issued	$-58M	·	·	·	$1.34B	·	·	·	$2.42B	·	·	·	$-550M	·	·	·
Stock Repurchased	$1.57B	$2.56B	$2.50B	$2.50B	$2.51B	$1.70B	$1.79B	$1.37B	$1.18B	$910M	$1.14B	$915M	$846M	$1.52B	$698M	$2.68B
Net Stock Activity	$-1.57B	·	·	·	$-2.51B	·	·	·	$-1.18B	·	·	·	$-846M	·	·	·
Dividends Paid	$183M	$162M	$166M	$171M	$180M	$165M	$169M	$171M	$185M	$160M	$162M	$164M	$175M	$156M	$160M	$160M
Financing Cash Flow	$-830M	$-999M	$-2.97B	$-3.09B	$-1.50B	$-2.16B	$-110M	$-1.09B	$-1.22B	$-1.04B	$-1.13B	$-1.20B	$-725M	$-1.84B	$-2.32B	$-1.93B
Net Change in Cash	$-100M	$43M	$58M	$-121M	$-873M	$-955M	$2.06B	$-453M	$349M	$44M	$29M	$20M	$-66M	$-91M	$141M	$-1.51B
Taxes Paid	$-5M	$1.51B	$81M	$136M	$10M	$358M	$487M	$998M	$1M	$316M	$297M	$766M	$7M	$244M	$322M	$606M
Free Cash Flow	$895M	·	·	·	$660M	·	·	·	$1.35B	·	·	·	$606M	·	·	·
Levered FCF	$421M	·	·	·	$231M	·	·	·	$940M	·	·	·	$221M	·	·	·

Rentabilität 5

Vierteljährliche Rentabilität-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Net Margin	8.5%	·	8.6%	8.9%	8.8%	·	7.3%	8.3%	9.2%	·	6.7%	7.5%	8.7%	·	7.6%	7.8%
Pretax Margin	12.0%	·	12.6%	13.0%	12.7%	·	10.9%	12.8%	13.0%	·	10.1%	11.4%	12.3%	·	11.4%	11.9%
EBITDA Margin	4.9%	·	4.6%	4.6%	4.7%	·	4.8%	4.7%	4.6%	·	4.7%	4.8%	4.9%	·	5.0%	5.0%
ROA	2.7%	·	2.8%	2.8%	2.8%	·	2.2%	2.6%	2.9%	·	2.0%	2.3%	2.6%	·	2.2%	2.3%
ROE	-33.0%	·	-43.7%	-55.2%	-62.7%	·	-54.5%	-74.9%	-77.4%	·	-36.9%	-39.9%	-60.2%	·	-55.8%	-54.1%

Liquidität & Solvenz 4

Vierteljährliche Liquidität & Solvenz-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	0.8	·	0.9	1.0	1.2	·	1.1	1.1	1.2	·	1.2	1.2	1.2	·	1.4	1.5
Quick Ratio	0.6	·	0.6	0.7	0.9	·	0.9	0.8	0.9	·	0.8	0.8	0.9	·	1.0	1.1
Debt / Equity	-6.3	·	-7.2	-9.0	-12.7	·	-19.7	-25.6	-24.9	·	-15.9	-16.9	-15.6	·	-11.2	-10.6
LT Debt / Equity	-6.3	·	-7.2	-9.0	-11.7	·	-17.5	-22.7	-23.0	·	-14.9	-15.9	-14.6	·	-11.1	-10.5

Effizienz 2

Vierteljährliche Effizienz-Daten für HCA
Kennzahl	Trend	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.3	·	0.3	0.3	0.3	·	0.3	0.3	0.3	·	0.3	0.3	0.3	·	0.3	0.3
Receivables Turnover		1.7	·	1.9	1.8	1.7	·	1.8	1.8	1.9	·	1.8	1.8	1.8	·	1.8	1.8

Pro Aktie 6

Vierteljährliche Pro Aktie-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$-28.32	·	$-23.21	$-18.61	$-14.48	·	$-8.57	$-6.17	$-6.14	·	$-9.21	$-8.44	$-9.04	·	$-11.87	$-12.82
Revenue / Share	$84.31	·	$81.13	$76.91	$73.45	·	$67.28	$66.24	$64.69	·	$58.87	$57.01	$55.49	·	$51.65	$50.06
Cash Flow / Share	$8.89	·	·	·	$6.62	·	·	·	$9.21	·	·	·	$6.42	·	·	·
Cash / Share	$4.22	·	$4.34	$3.98	$4.36	·	$11.35	$3.21	$4.88	·	$3.31	$3.16	$3.05	·	$3.52	$2.99
Dividend / Share	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1	$1
EPS (TTM)	$27.39	·	$25.12	$23.69	$22.79	·	$20.25	$19.66	$18.98	·	$16.96	$16.95	$16.80	·	$18.95	$19.40

Bewertung (TTM) 14

Vierteljährliche Bewertung (TTM)-Daten für HCA
Kennzahl	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$75.20B	·	$73.57B	$71.91B	$70.64B	·	$68.53B	$66.91B	$65.00B	·	$62.64B	$61.24B	$60.33B	·	$60.01B	$59.48B
Net Income TTM	$6.53B	·	$6.18B	$5.99B	$5.93B	·	$5.40B	$5.32B	$5.23B	·	$4.77B	$4.84B	$4.92B	·	$5.83B	$6.15B
Market Cap	$105.31B	·	$97.96B	$90.47B	$83.95B	·	$103.44B	$83.29B	$87.79B	·	$66.16B	$82.83B	$72.76B	·	$52.18B	$48.23B
Enterprise Value	$143.86B	·	$135.36B	$128.91B	$127.47B	·	$143.52B	$123.34B	$126.70B	·	$104.62B	$120.90B	$110.77B	·	$88.89B	$86.28B
P/E	17.3	·	17.0	16.2	15.2	·	20.1	16.3	17.6	·	14.5	17.9	15.7	·	9.7	8.7
P/S	1.4	·	1.3	1.3	1.2	·	1.5	1.2	1.4	·	1.1	1.4	1.2	·	0.9	0.8
P/B	-16.7	·	-18.4	-20.6	-23.9	·	-47.4	-52.1	-54.4	·	-26.7	-36.0	-29.2	·	-15.5	-13.1
P / Cash Flow	52.3	·	·	·	50.8	·	·	·	35.6	·	·	·	40.4	·	·	·
P / FCF	117.7	·	·	·	127.2	·	·	·	65.0	·	·	·	120.1	·	·	·
EV / EBITDA	154.7	·	152.3	149.4	148.2	·	170.5	150.6	159.4	·	136.0	158.5	146.5	·	118.7	116.9
EV / FCF	160.7	·	·	·	193.1	·	·	·	93.8	·	·	·	182.8	·	·	·
EV / Revenue	1.9	·	1.8	1.8	1.8	·	2.1	1.8	1.9	·	1.7	2.0	1.8	·	1.5	1.5
Earnings Yield	5.8%	·	5.9%	6.2%	6.6%	·	5.0%	6.1%	5.7%	·	6.9%	5.6%	6.4%	·	10.3%	11.5%
Payout Ratio	11.3%	·	·	·	11.2%	·	·	·	11.6%	·	·	·	12.8%	·	·	·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Umsatz	$75.60B	$70.60B	$64.97B	$60.23B	$58.75B
Nettoergebnis	$6.78B	$5.76B	$5.24B	$5.64B	$6.96B
Verwässerte EPS	$28.33	$22.00	$18.97	$19.15	$21.16

Bilanz

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fremdkapital / Eigenkapital	-6.9	-17.2	-22.3	-13.8	-37.1
Liquiditätsgrad	1.0	1.1	1.2	1.4	1.4
Quick Ratio	0.7	0.8	0.9	1.0	1.0

Cashflow

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Freier Cashflow	$7.69B	$5.64B	$4.69B	$4.13B	$5.38B

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027 Yahoo Finance · 3 Wochen, 2 Tage vor
HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue Yahoo Finance · 3 Wochen, 6 Tage vor
Bemerkenswerte Optionsaktivität am Donnerstag: HCA, HRTG, ZM Nasdaq · 1 Monat, 1 Woche vor
HCA Healthcare (HCA) Finanzierungsstrategie erweitert – Hier erfahren Sie wie Yahoo Finance · 1 Monat, 2 Wochen vor
HCA Healthcare übertrifft Schätzungen für den vierteljährlichen Gewinn aufgrund der Nachfrage nach medizinischer Versorgung Yahoo Finance · 2 Monate, 1 Woche vor

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

HCA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

HCA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

Gleitende Durchschnitte und Überlagering

Volumen

Oszillatoren

Momentum und Trend

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

HCA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

12-Monats-Kursziel

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten